Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms
Open Access
- 1 January 2006
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2006 (1), 438-443
- https://doi.org/10.1182/asheducation-2006.1.438
Abstract
The association between cancer and thrombosis is well recognized. What is not known, however, is the exact relationship between these two common medical conditions. Although the development of venous thromboembolism (VTE) in a patient with known cancer is the most common presentation, in some patients, VTE may precede the diagnosis of malignancy by many months. The variation in clinical presentation is likely due to the heterogeneous biology of different tumor types and also reflects the limitations of detection or available diagnostic methods. Accumulating evidence now suggests that critical oncogenic events may also trigger activation of the coagulation cascade, leading to a prothrombotic environment that not only manifests as venous thromboembolic disease but also promotes the growth and progression of the malignancy. This chapter will review the evidence for screening for occult malignancy in patients presenting with unprovoked or idiopathic thrombosis, briefly outline the known biological relationships between malignancy and thrombosis, and summarize the clinical data on the potential anticancer effects of low molecular weight heparins (LMWHs).Keywords
This publication has 36 references indexed in Scilit:
- Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528 693 AdultsArchives of Internal Medicine, 2005
- Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort studyBritish Journal of Cancer, 2004
- Venous Thromboembolism and Cancer: Risks and OutcomesCirculation, 2003
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000
- Undiagnosed malignancy in patients with deep vein thrombosisCancer, 1998
- The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary EmbolismNew England Journal of Medicine, 1998
- Venous thromboembolism and cancerThe Lancet, 1998
- Deep venous thrombosis and occult malignancy: an epidemiological studyBMJ, 1994
- Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic CancerNew England Journal of Medicine, 1992